ORIGINAL RESEARCH
Accepted on 14 Nov 2025
- Frontiers in Medicine
- Hematology
- Research Topics
- Advancing Therapeutic Strategies for Relapsed/Refractory Acute Lymphoblastic Leukemia
Advancing Therapeutic Strategies for Relapsed/Refractory Acute Lymphoblastic Leukemia
1,437
Total downloads
7,114
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 03 Oct 2025
Efficacy and safety of the third-generation tyrosine kinase inhibitor Olverembatinib in relapsed and persistent minimal residual disease positive Philadelphia chromosome-positive acute lymphoblastic leukemia patients
doi 10.3389/fmed.2025.1662512
- 1,202 views
ORIGINAL RESEARCH
Published on 08 Sep 2025
Serum proteome profiling identified thrombospondin-1 and lactoferrin as biomarkers of relapsed multiple myeloma
doi 10.3389/fmed.2025.1640245
- 1,087 views
CASE REPORT
Published on 14 Jan 2025
Venetoclax in combination with chidamide and azacitidine for the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia with the MLL-AF4 gene: a case report and literature review
doi 10.3389/fimmu.2024.1475974
- 2,544 views
- 3 citations
